The global dual-channel Deep Brain Stimulation (DBS) devices market is booming, projected to reach $2.725 billion by 2033 with an 8% CAGR. Driven by rising neurological disorders and technological advancements, this in-depth analysis covers market size, key players (Medtronic, Boston Scientific), regional trends, and future growth projections for rechargeable and non-rechargeable DBS systems.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
